Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says
In Brief: Columiba Adds Presbyterian to Center’s Name: Clinton’s Mother Honored; DeVita move Rumored
NIH Director Healy Resigned, To Return To Cleveland In June’ Kessler To Remain
Sen. Pryor Attacks Drug Industry, NIH Technology Transfer
Clinton Names Broadnax HHS Deputy, Others to Sub-Cabinet Posts
Trial Needed Of PSA To Determine Patients To Test, Chabner Says
DCT Advisors Okay PA In Imaging Patters Of Care RFA; Contracts
IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes
Trending Stories
- As fire encroached, City of Hope prepared to evacuate its Duarte campus
- Trump 2016: A look back at the 45th president’s impact on oncology
- Gonzalez-Angulo To Serve 10 Years In Poisoning Case
- David Lauren: We’re focused on cancer. This isn’t about just sending a check. This is our mission.
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - After 25 years as FDA’s chief cancer strategist, Richard Pazdur reflects on opportunities for change at the agency